CIK: 1751790 - Address: C/O Rain Oncology Inc., 8000 Jarvis Avenue, Newark, CA 94560
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/2/23 16:33
5/1/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWolff StefaniCAOEVP,COOS.d-39.8800-56D
2/1/23 16:18
1/30/23
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWolff StefaniCAOEVP,COOS.d-511.7800-104D
11/1/22 19:32
10/31/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWolff StefaniCAOEVP,COOS.d-512.8800-93D
8/2/22 17:48
8/1/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWolff StefaniCAOEVP,COOS.d-615.6700-221D
5/3/22 19:04
5/2/22
NRIXNurix Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWolff StefaniCAOEVP,COOS.d-411.7500-341D
6/17/20 21:52
6/15/20
PRNBPrincipia Biopharma Inc.DEHealthDrugPharmaceutical PreparationsWolff StefaniCAOChief DeS-33460.750-6-2219D
6/17/20 21:48
3/16/20
PRNBPrincipia Biopharma Inc.DEHealthDrugPharmaceutical PreparationsWolff StefaniCAOChief DeS.a-25446.150-6-1825D
6/17/20 21:41
12/16/19
PRNBPrincipia Biopharma Inc.DEHealthDrugPharmaceutical PreparationsWolff StefaniCAOChief DeS.a-27249.430-6-1530D
3/18/20 17:08
3/16/20
PRNBPrincipia Biopharma Inc.DEHealthDrugPharmaceutical PreparationsWolff StefaniCAOChief DeS.d-25446.150-6-1336D
12/18/19 19:09
12/16/19
PRNBPrincipia Biopharma Inc.DEHealthDrugPharmaceutical PreparationsWolff StefaniCAOChief DeS.d-27249.430-6-1336D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact